Company / CapEx per Share
Acadia Pharmaceuticals CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.03
FY2025
5-year range
$0.00 / $0.03
FY2021-FY2025
Trend
+785.7%
vs FY2024
Sector context
#87 of 192
Health Care
What the data says
CapEx per Share changed +786% YoY in FY2025, a notable deviation from the 8-year average annual change of +262%.
Based on SEC 10-K filings.
0.03 in FY2025 with a 5-year CAGR of -10.5%.
Improved from $0.00 to $0.03 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -10.5%
- 10-Year CAGR
- -
Sector benchmark
#87 of 192 in Health CareTop 45% of 192This company $0.03 Sector average $2.46
▼
-98.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 785.7% year-over-year.
- Ranks #87 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2022.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | +785.7% |
| FY2024 | $0.00 | +929.6% |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.01 | -85.6% |
| FY2020 | $0.05 | +522.6% |
| FY2019 | $0.01 | -53.6% |
| FY2018 | $0.02 | +152.8% |
| FY2017 | $0.01 | -54.7% |
| FY2016 | $0.01 | -31.0% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026